Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A magic drug target: Androgen receptor
Dan Li, Wenfang Zhou, Jinping Pang, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 5, pp. 1485-1514
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Boosting Protein–Ligand Binding Pose Prediction and Virtual Screening Based on Residue–Atom Distance Likelihood Potential and Graph Transformer
Chao Shen, Xujun Zhang, Yafeng Deng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10691-10706
Closed Access | Times Cited: 113
PROTAC-DB 2.0: an updated database of PROTACs
Gaoqi Weng, Xuanyan Cai, Dongsheng Cao, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1367-D1372
Open Access | Times Cited: 97
The role of androgens in women's health and wellbeing
Vittorio Emanuele Bianchi, Elena Bresciani, Ramona Meanti, et al.
Pharmacological Research (2021) Vol. 171, pp. 105758-105758
Closed Access | Times Cited: 50
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1233-1318
Open Access | Times Cited: 19
Exploring the nexus of nuclear receptors in hematological malignancies
Mukesh Kumar Manickasamy, Anjana Sajeev, Bandari BharathwajChetty, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives
Si Ha, Guoshun Luo, Hua Xiang
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16128-16154
Closed Access | Times Cited: 24
The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia
Kaitao Li, Yang Sun, Shizhao Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3307-3323
Open Access | Times Cited: 15
WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation
Kai Song, He Sun, Bin Tu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107931-107931
Open Access | Times Cited: 13
A potent new-scaffold androgen receptor antagonist discovered on the basis of a MIEC-SVM model
Xinyue Wang, Xin Chai, Luhu Shan, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 9, pp. 1978-1991
Closed Access | Times Cited: 5
Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome
Ruiqiong Zhou, Shang Li, Jiansheng Liu, et al.
EBioMedicine (2020) Vol. 52, pp. 102635-102635
Open Access | Times Cited: 35
Pyridine Moiety: An Insight into Recent Advances in the Treatment of Cancer
Rakesh Sahu, Rakhi Mishra, Rajnish Kumar, et al.
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 2, pp. 248-272
Closed Access | Times Cited: 29
Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer
Xiaoli Li, Duanfang Zhou, Yongqing Cai, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 20
Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer
Tianshi Yu, Chanin Nantasenamat, Supicha Kachenton, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6729-6742
Open Access | Times Cited: 12
Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer
Weitao Fu, Hao Yang, Chenxian Hu, et al.
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 675-684
Open Access | Times Cited: 11
Bromodomain-containing protein 4 activates androgen receptor transcription and promotes ovarian fibrosis in PCOS
Daojuan Wang, Zhengquan Zhu, Yu Fu, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113090-113090
Open Access | Times Cited: 11
Recent advances in dietary androgen receptor inhibitors
Li Ren, Tiehua Zhang, Jie Zhang
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1446-1500
Closed Access | Times Cited: 4
Crab-shaped DNA tetrahedral nanomachine for silencing undruggable mRNA targets in prostate cancer
Fangning Wan, Zheng Liu, Junyu Zhang, et al.
Nano Today (2024) Vol. 55, pp. 102187-102187
Open Access | Times Cited: 4
Androgen Receptor Mediates Dopamine Agonist Resistance by Regulating Intracellular reactive oxygen species (ROS) in Prolactin-secreting Pituitary Adenoma
Linpeng Xu, Zhuowei Lei, Quanji Wang, et al.
Antioxidants and Redox Signaling (2024)
Closed Access | Times Cited: 4
Discovery of Novel Tetrahydroquinoline Derivatives as Potent, Selective, and Orally Available AR Antagonists
Leer Yuan, Jianing Liao, Yiyang Qin, et al.
European Journal of Medicinal Chemistry (2025), pp. 117566-117566
Closed Access
Ran drives pancreatic cancer metastasis by activating the osteopontin-PI3K/AKT-androgen receptor signaling cascade
Linhong Deng, Jingyi Ren, Dong Liu, et al.
Toxicology and Applied Pharmacology (2025), pp. 117328-117328
Closed Access
Monoubiquitination in Homeostasis and Cancer
Yujie Chen, Dandan Zhou, Yinan Yao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5925-5925
Open Access | Times Cited: 17
Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatment
Ruixiang Luo, Weitao Fu, Jingjing Shao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 253, pp. 115305-115305
Closed Access | Times Cited: 9
Effects of testosterone dose on depression-like behavior among castrated adult male rats
Zhongyu Ren, Ling Xiao, Yinping Xie, et al.
Psychoneuroendocrinology (2024) Vol. 165, pp. 107046-107046
Closed Access | Times Cited: 3
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
Manuel Abreu, Pablo Cabezas‐Sainz, Thais Pereira‐Veiga, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 353-353
Open Access | Times Cited: 24
Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs
Ioannis Avgeris, Dimanthi Pliatsika, Sotiris S. Nikolaropoulos, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106089-106089
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top